VySpine earned FDA 510(k) clearance for its DiversiVy facet screw, according to a March 23 news release.
DiversiVy is designed for the lumbosacral spine to aid in fusions. It is indicated for posterior surgical treatment with or without bone graft at one or multiple levels.
DiversiVy is used to address conditions including spondylolisthesis, spondylolysis and pseudoarthrosis.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
